Thalassemia major is mainly treated symptomatically, including blood transfusion, splenectomy, active treatment of triggers, etc. Allogeneic hematopoietic stem cell transplantation is the radical cure.
Thalassemia is an abnormality of one or more bead protein genes, which triggers one or more bead protein production disorders, resulting in insufficient synthesis of normal hemoglobin and causing anemia.
For thalassemia major, blood transfusion therapy can be performed to transfuse red blood cells and relieve the symptoms of anemia. When hypersplenism or splenomegaly with obvious compression occurs, splenectomy treatment can be performed. Aggressive anti-infective treatment can be given for factors inducing hemolysis, such as infection.
Thalassemia is a hereditary hemolytic anemia, and currently the only radical treatment is allogeneic hematopoietic stem cell transplantation, choosing a donor with matching human leukocyte antigens.
All of the above treatment options need to be carried out under the guidance of a professional doctor. When thalassemia major occurs, it is recommended to consult a doctor in time and standardize the treatment.